• DELIVER Subanalysis 'Seals Deal' for Dapagliflozin in HF

    1 month ago - By Medscape

    An analysis of the large global DELIVER trial found that dapagliflozin improved outcomes and symptoms across a wide range of patients with heart failure.
    MDedge News
    Read more ...